Phio Pharmaceuticals Corp.
Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)

Last updated:

Abstract:

Aspects of the invention relate to methods for treating ALS comprising administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule that is directed against a gene encoding superoxide dismutase 1 (SOD1).

Status:
Grant
Type:

Utility

Filling date:

6 Jul 2016

Issue date:

11 May 2021